Next-gen T-cell player Neogene bolsters U.S. team, adding Bristol Myers vet as COO

Brent Pfeiffenberger grew up at Bristol Myers Squibb, developing as a leader over a nearly 19-year tenure at the Big Pharma. Now, he’s taking his experience into the biotech world as the chief operating officer of Neogene Therapeutics,